Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Heisser

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Epidemiology|November 8, 2025
Overcoming prevalence bias in colorectal cancer screening studies by sensible analyses rather than ignoring it or giving up relevant effect measuresHermann Brenner, Thomas Heisser, Michael Hoffmeister
Gut|March 7, 2023
Significant underestimation of preventive effects in colorectal cancer screening trialThomas Heisser, Michael Hoffmeister, Hermann Brenner
International Journal of Cancer|December 15, 2020
Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov modelThomas Heisser, Michael Hoffmeister, Hermann Brenner
International Journal of Cancer|December 10, 2021
Model based evaluation of long-term efficacy of existing and alternative colorectal cancer screening offers: A case study for GermanyThomas Heisser, Michael Hoffmeister, Hermann Brenner
JAMA Network Open|October 1, 2024
Delayed Cancer Registration and Estimation of Screening Colonoscopy EffectsHermann Brenner, Thomas Heisser, Michael Hoffmeister
Expert Review of Anticancer Therapy|December 4, 2024
Arguments for and against extending the interval between colonoscopies following negative results in colorectal cancer screeningMichael Hoffmeister, Thomas Heisser, Hermann Brenner
European Journal of Epidemiology|July 8, 2025
Looking at randomized trials with the critical eyes of epidemiologists: the case of screening colonoscopyHermann Brenner, Thomas Heisser, Michael Hoffmeister
Health Policy (Amsterdam, Netherlands)|September 16, 2016
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and AustraliaKatharina Elisabeth Fischer, Thomas Heisser, Tom Stargardt
Plos Medicine|July 18, 2020
Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluationThomas Heisser, Korbinian Weigl, Michael Hoffmeister, et al.
Annals of Internal Medicine|May 12, 2025
Dollars Needed to Pay per Early-Detected Colorectal Cancer Case in Stool-Based ScreeningHermann Brenner, Teresa Seum, Thomas Heisser, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Epidemiology|November 8, 2025
Overcoming prevalence bias in colorectal cancer screening studies by sensible analyses rather than ignoring it or giving up relevant effect measuresHermann Brenner, Thomas Heisser, Michael Hoffmeister
Gut|March 7, 2023
Significant underestimation of preventive effects in colorectal cancer screening trialThomas Heisser, Michael Hoffmeister, Hermann Brenner
International Journal of Cancer|December 15, 2020
Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov modelThomas Heisser, Michael Hoffmeister, Hermann Brenner
International Journal of Cancer|December 10, 2021
Model based evaluation of long-term efficacy of existing and alternative colorectal cancer screening offers: A case study for GermanyThomas Heisser, Michael Hoffmeister, Hermann Brenner
JAMA Network Open|October 1, 2024
Delayed Cancer Registration and Estimation of Screening Colonoscopy EffectsHermann Brenner, Thomas Heisser, Michael Hoffmeister
Expert Review of Anticancer Therapy|December 4, 2024
Arguments for and against extending the interval between colonoscopies following negative results in colorectal cancer screeningMichael Hoffmeister, Thomas Heisser, Hermann Brenner
European Journal of Epidemiology|July 8, 2025
Looking at randomized trials with the critical eyes of epidemiologists: the case of screening colonoscopyHermann Brenner, Thomas Heisser, Michael Hoffmeister
Health Policy (Amsterdam, Netherlands)|September 16, 2016
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and AustraliaKatharina Elisabeth Fischer, Thomas Heisser, Tom Stargardt
Plos Medicine|July 18, 2020
Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluationThomas Heisser, Korbinian Weigl, Michael Hoffmeister, et al.
Annals of Internal Medicine|May 12, 2025
Dollars Needed to Pay per Early-Detected Colorectal Cancer Case in Stool-Based ScreeningHermann Brenner, Teresa Seum, Thomas Heisser, et al.
Pageof 6